光动力疗法
抗菌剂
光敏剂
组合化学
位阻效应
单线态氧
生物膜
化学
药品
合理设计
纳米技术
金黄色葡萄球菌
材料科学
光化学
抗菌活性
作者
Fan Zhang,Xiao‐Yun Ran,Bo‐Jian Han,Long-Xuan Li,Ya-Song Cao,Xiao‐Qi Yu,Kun Li
摘要
ABSTRACT Biofilm‐associated infections represent a major clinical challenge owing to intrinsic hypoxia, restricted drug penetration and antimicrobial resistance. Among non‐antibiotic strategies, antimicrobial photodynamic therapy (a‐PDT) is particularly attractive owing to its spatiotemporal controllability, low systemic toxicity and multi‐target oxidative damage. However, most organic photosensitizers predominantly operate through oxygen‐dependent Type‐II pathways, rendering PDT severely compromised in hypoxic biofilm microenvironments. Although Type‐I PDT offers an oxygen‐insensitive alternative, its rational development is fundamentally restricted by the energy gap law. Herein, a steric‐control strategy is developed to regulate the triplet excited‐state alignment of dibenzofulvene‐based photosensitizers and enable a predominant Type‐I radical pathway. Through pyridinium, quinolinium incorporation and regioisomeric engineering, three dibenzofulvene‐based photosensitizers (FEMP, FEOMQ, and FEMQ) were constructed. Para‐quinolinium substituted FEMQ exhibits the narrowest Δ E S1‐T2 and dominant Type‐I ROS generation. Consequently, FEMQ achieves rapid eradication of methicillin‐resistant Staphylococcus aureus (MRSA) at ultralow concentrations, efficient biofilm disruption, and significant therapeutic efficacy in a biofilm‐associated implanted catheter model. Overall, this work establishes dibenzofulvene‐based, sterically regulated photosensitizers as a rational platform for efficient Type‐I photodynamic antibacterial therapy and offers a promising non‐antibiotic strategy for persistent biofilm‐associated infections.
科研通智能强力驱动
Strongly Powered by AbleSci AI